Live Chat ×
Skip to main content

Targeted Therapies on MDS and AML Treatment

Dr. Levis addresses how targeting particular genetic mutations may determine treatment decisions for myeloid malignancies. (Recorded Dec. 2017).

Recorded at the 2017 AAMDSIF/Cleveland Clinic Satellite Symposium Preceding the American Society of Hematology Annual Meeting.

Symposium Title: A Brave New World – The Clinical Management of Bone Marrow Failure and Myeloid Malignancy in a Time of Personalized Therapy